Workshop spotlights how expertly curated clinical literature accelerates oncology trial design, label expansion, and treatment decisions.
Genomenon, a leading genomic intelligence company, will host a corporate workshop at the Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo, taking place November 11–15, 2025 at the Boston Convention & Exhibition Center.
Workshop Details
This workshop demonstrates, with data-backed case studies, how literature-based real-world evidence (RWE) augments traditional real-world data by uncovering patient- and variant-specific insights across thousands of peer-reviewed publications. We will show how systematically curated literature improves decisions in pharma - optimizing trial design (eligibility, endpoints, and feasibility), informing label-expansion strategy, and deepening disease understanding - alongside clinical applications where curated evidence supports treatment selection and trial matching in Genomenon’s Cancer Knowledgebase (CKB). Using oncology examples, we will walk through how integrated literature evidence - variant findings, efficacy data, clinical guidelines, patient characteristics, and trial criteria - enables more accurate patient stratification and more precise therapeutic decisions in precision oncology.
What You’ll Learn
About Genomenon
Genomenon is a leading genomic intelligence company transforming patient care by uncovering the genomic drivers of genetic disease and cancer. By combining the power of AI built on the world’s premier genomic data set with genomic expertise, the company simplifies complex genetic data into actionable insights. Genomenon's integrated software, data, and services solutions empower clients with advanced patient diagnosis and precision medicine development.
About AMP 2025 Annual Meeting & Expo
The Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo will be held November 11–15, 2025 in Boston, Massachusetts, bringing together the global molecular diagnostics community for scientific sessions, corporate workshops, and exhibits.
Schedule a meeting with our team in Boston: hello@genomenon.com
Genomenon is a leading genomic intelligence company transforming patient care by uncovering the genomic drivers of genetic disease and cancer. By combining the power of AI built on the world’s premier genomic data set with genomic expertise, the company simplifies complex genetic data into actionable insights. Genomenon's integrated software, data, and services solutions empower clients with advanced patient diagnosis and precision medicine development.
